Burning Rock Biotech Limited (BNR)
NASDAQ: BNR · Real-Time Price · USD
21.56
+0.89 (4.31%)
At close: Apr 20, 2026, 4:00 PM EDT
21.56
0.00 (0.00%)
After-hours: Apr 20, 2026, 4:00 PM EDT
Burning Rock Biotech Market Cap
Burning Rock Biotech has a market cap or net worth of $232.13 million as of April 20, 2026. Its market cap has increased by 429.91% in one year.
Market Cap
232.13M
Enterprise Value
165.91M
1-Year Change
429.91%
Ranking
Category
Stock Price
$21.56
Market Cap Chart
Since June 12, 2020, Burning Rock Biotech's market cap has decreased from $2.51B to $232.13M, a decrease of -90.74%. That is a compound annual growth rate of -33.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 222.55M | 2.58% |
| Dec 31, 2025 | 216.95M | 213.30% |
| Dec 31, 2024 | 69.25M | -29.38% |
| Dec 29, 2023 | 98.06M | -58.57% |
| Dec 30, 2022 | 236.67M | -76.25% |
| Dec 31, 2021 | 996.35M | -58.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 12, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OPKO Health | 941.24M |
| Castle Biosciences | 758.91M |
| Personalis | 704.48M |
| Myriad Genetics | 475.02M |
| Fulgent Genetics | 468.73M |
| Prenetics Global | 300.05M |
| Biodesix | 132.81M |
| Insight Molecular Diagnostics | 123.53M |